Tilray is expanding its operations and research efforts to Europe, where medical cannabis laws and attitudes are rapidly evolving.
Tilray’s European activities are based on the two key pillars of providing highest quality, pharmaceutical-grade cannabis to patients and working in close cooperation with institutions for clinical research trials to advance the study, knowledge base and practical applications of cannabis used for medical and therapeutic purposes.
All Tilray medical cannabis is laboratory tested to ensure quality and safety, is delivered with full descriptions of each strain’s specific cannabinoid profile and meets the highest standards for pharmaceutical products.
TO LEARN MORE ABOUT PARTNERING WITH TILRAY IN EUROPE:
Director of Business Development, Europe